A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
Samir S. Deeb, Lluis Fajas A, Masami Nemoto et al. · Nature Genetics · 1998
Cited by 1,318 works. doi:10.1038/3099
Authors
- Samir S. Deeb
- Lluis Fajas A
- Masami Nemoto
- Jussi Pihlajamäki
- Leena Moilanen Mykkänen
- Johanna Kuusisto
- Markku Laakso
- Wilfred Y. Fujimoto
- Johan H. Auwerx
References
- Role of Insulin Resistance in Human Disease
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
- A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
- Adipogenesis and Obesity: Rounding Out the Big Picture
- Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
- Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes
- A genome–wide search for human non–insulin–dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2